Ignite Creation Date:
2024-05-06 @ 10:25 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03257267
Status:
COMPLETED
Last Update Posted:
2023-07-11
First Post:
2017-07-26
Brief Title:
Study of Cemiplimab in Adults With Cervical Cancer
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-26
First Submit QC Date:
August 17 2017
Study First Post Date:
2017-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-04-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-25
Last Update Post Date:
2023-07-11
Last Update Post Date Type:
ACTUAL